Sequent Scientific Key Ratios
NSE: SEQUENT | BSE: 512529
₹267.40
As on 28-Aug-2026IST
Market cap
₹11,757 Cr
Revenue (TTM)
₹3,149 Cr
P/E Ratio
68.7
P/B Ratio
4.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 2.87 | 19.54 | 16.33 | 30.62 | 17.82 |
| EBIT | -5.84 | 84.57 | 127.71 | 110.38 | 23.83 |
| Net Profit | 26.41 | 101.85 | 70.70 | 72.75 | 17.36 |
| EPS | 26.40 | 18.67 | 97.57 | 60.67 | 5.15 |
| Book Value | -- | -- | -31.16 | 33.96 | 16.40 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| -2.25 | 3.62 | 12.63 | 12.25 | 4.83 |
| Net Margin
| 3.25 | -0.11 | 6.70 | 6.49 | 0.52 |
| Return on equity
| 1.94 | -1.41 | 10.42 | 9.06 | 1.11 |
| Return on Capital
| 2.69 | 2.92 | -- | 13.10 | 4.80 |
| Return on Assets
| 1.55 | -0.26 | 6.86 | 5.25 | 0.57 |
| Debt to Equity (x)
| -- | -- | 0.10 | 0.16 | 0.27 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
--
|
13.10
|
4.80
|
-0.60
|
-9.71
|
|
Peer Median
|
--
|
19.27
|
22.77
|
18.19
|
--
|
ROE
10.42
Lower than Peers by 6.58
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
10.42
|
9.06
|
1.11
|
-4.85
|
-18.95
|
|
Peer Median
|
17.00
|
16.19
|
16.63
|
14.89
|
--
|
ROA
6.86
Lower than Peers by 6.37
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
6.86
|
5.25
|
0.57
|
-1.96
|
-8.21
|
|
Peer Median
|
13.24
|
11.81
|
12.17
|
11.85
|
--
|
EBIT Margin
12.63
Lower than Peers by 12.24
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
12.63
|
12.25
|
4.83
|
-0.01
|
-3.08
|
|
Peer Median
|
24.87
|
23.41
|
23.35
|
23.04
|
--
|
Net Margin
6.70
Lower than Peers by 12.86
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
6.70
|
6.49
|
0.52
|
-2.14
|
-8.55
|
|
Peer Median
|
19.57
|
17.37
|
19.25
|
17.52
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
--
|
13.40
|
8.46
|
2.26
|
-4.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
16.33
Higher than Peers by 4.08
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
16.33
|
13.75
|
119.52
|
-3.60
|
0.57
|
|
Peer Median
|
12.26
|
16.35
|
8.42
|
13.28
|
--
|
EBIT Growth
127.71
Higher than Peers by 108.42
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
127.71
|
188.31
|
1,15,409.52
|
99.71
|
-175.61
|
|
Peer Median
|
19.29
|
8.10
|
14.90
|
27.51
|
--
|
Net Profit Growth
70.70
Higher than Peers by 43.22
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
70.70
|
1,324.82
|
153.24
|
75.72
|
-372.49
|
|
Peer Median
|
27.49
|
7.69
|
15.40
|
24.45
|
--
|
EPS Growth
97.57
Higher than Peers by 73.54
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
97.57
|
337.51
|
164.51
|
70.40
|
-394.57
|
|
Peer Median
|
24.03
|
10.18
|
21.00
|
23.62
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
--
|
20.14
|
288.72
|
-9.84
|
-0.39
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.10
Higher than Peers by 0.10
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
0.10
|
0.16
|
0.27
|
0.78
|
0.62
|
|
Peer Median
|
0.00
|
0.05
|
0.04
|
0.06
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
--
|
0.04
|
0.08
|
0.37
|
0.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.38
Lower than Peers by 0.47
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
2.38
|
2.38
|
1.76
|
1.28
|
1.40
|
|
Peer Median
|
2.86
|
2.82
|
2.59
|
2.37
|
--
|
Quick Ratio
1.53
Lower than Peers by 0.79
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
1.53
|
1.53
|
1.08
|
0.75
|
0.78
|
|
Peer Median
|
2.32
|
2.31
|
2.33
|
1.98
|
--
|
Interest Coverage
6.90
Lower than Peers by 42.45
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
6.90
|
6.04
|
1.15
|
-0.14
|
-2.88
|
|
Peer Median
|
49.34
|
45.61
|
47.50
|
43.36
|
--
|
Operating Efficiency
Debtors to sales
33.20
Higher than Peers by 7.88
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
33.20
|
30.56
|
26.82
|
24.50
|
24.00
|
|
Peer Median
|
25.31
|
19.84
|
24.81
|
26.71
|
--
|
Asset Turnover
1.01
Higher than Peers by 0.42
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
1.01
|
0.80
|
1.08
|
0.94
|
0.98
|
|
Peer Median
|
0.59
|
0.61
|
0.74
|
0.71
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
--
|
98.80
|
69.32
|
87.51
|
84.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
--
|
79.26
|
62.42
|
89.54
|
87.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
--
|
126.90
|
91.93
|
119.04
|
109.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
--
|
51.16
|
39.81
|
58.01
|
61.25
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
68.69
Higher than Peers by 30.99
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
68.69
|
45.14
|
141.01
|
--
|
--
|
|
Peer Median
|
37.70
|
37.70
|
36.17
|
29.15
|
--
|
Price / Book Value
4.18
Lower than Peers by 1.09
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
4.18
|
2.96
|
1.45
|
4.96
|
2.82
|
|
Peer Median
|
5.27
|
5.27
|
5.47
|
5.43
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.76
|
0.76
|
0.97
|
0.66
|
--
|
EV/EBITDA
18.80
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
18.80
|
11.74
|
8.87
|
45.01
|
118.11
|
|
Peer Median
|
--
|
31.54
|
37.18
|
37.79
|
--
|
Market Cap
11,757
Lower than Peers by 1,79,378
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Sequent Scientific
|
11,757
|
8,003
|
3,274
|
2,876
|
1,811
|
|
Peer Median
|
1,91,135
|
1,91,135
|
1,19,795
|
1,20,138
|
--
|